Brief: Ionis Announces Proposed Convertible Offering To Refinance 2026 Convertible Notes
11/11/2025 21:06
Nov 12 (Reuters) - Ionis Pharmaceuticals Inc IONS.O: IONIS ANNOUNCES PROPOSED CONVERTIBLE OFFERING TO REFINANCE 2026 CONVERTIBLE NOTES IONIS PHARMACEUTICALS INC - TO OFFER $700 MILLION CONVERTIBLE NOTES DUE 2030 IONIS PHARMACEUTICALS INC - GRANTS OPTION FOR ADDITIONAL $70 MILLION NOTES Source text: ID:nBwbFdtbka Further company coverage: IONS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ionis Pharmaceuticals
See all newsAnalysis: US prices for new drugs fell in 2025 as fewer costly gene therapies were launched
Brief: Ionis Announces License Agreement With Recordati For Zilganersen In Alexander Disease (Axd) In All Countries Outside The U.S.
Brief: Ionis Pharmaceuticals Says FDA Approved Tryngolza For Severe Hypertriglyceridemia
Brief: FDA Approves Treatment To Reduce Risk Of Acute Pancreatitis In Adults With Severe Hypertriglyceridemia
Brief: Ionis Announces Appointment Of Ludwig Hantson, Ph.D. To Board Of Directors